Table 1 of
Sharma, Mol Vis 2015; 21:974-984. Table 1 of
Sharma, Mol Vis 2015; 21:974-984.
Table 1. Nucleotide sequences of two validated RNAi and siRNA oligos used in the study.
| Smad2 RNAi-1 validated (5′ to 3′) | GAGCAGAACCTCTCTGAATTTGGTTTTGGCCACTGACTGACCAAATTCAGAGGTTCTGCT |
|---|---|
| Smad2 RNAi-2 validated (5′ to 3′) | GTGTAAAGGCCTGTTGTATCCCGTTTTGGCCACTGACTGACGGGATACAAGGCCTTTACA |
| Smad3 RNAi-1 validated (5′ to 3′) | GCACTGAGGCACTCTGCGAAGAGTTTTGGCCACTGACTGACTCTTCGCAGTGCCTCAGTG |
| Smad3 RNAi-2 validated (5′ to 3′) | GTTCATCTGGTGGTCACTGGTTGTTTTGGCCACTGACTGACAACCAGTGCACCAGATGAA |
| Smad4 RNAi-1 validated (5′ to 3′) | GTATGATGGTAAGTAGCTGGCTGTTTTGGCCACTGACTGACAGCCAGCTTTACCATCATA |
| Smad4 RNAi-2 validated (5′ to 3′) | GTTTCCGACCAGCCACCTGAAGGTTTTGGCCACTGACTGACCTTCAGGTCTGGTCGGAAA |
| TGIF1 siRNA-1 validated (5′ to 3′) | GCAUGGACAUUCCCUUGGATT |
| TGIF1 siRNA-2 validated (5′ to 3′) | GCACCGUUACAAUGCCUAUTT |
| TGIF2 siRNA-1 validated (5′ to 3′) | GCCUCCUAGCUGGGAUUGUTT |
| TGIF2 siRNA-2 validated (5′ to 3′) | GGACGACAGCCUUUAGUUUTT |